Delivery Order SPE2DR25D3103-SPE2DR26F9F66
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12,436.80 to AmerisourceBergen Drug Corp for GAMUNEX-C 20 Gram/200 ML Vial pharmaceutical product on November 14, 2025, with an ultimate completion date of December 8, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a $28,323.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 20 gram/200 milliliter vials with an ultimate completion date of August 22, 2025. This non-set-aside competitive award was issued on August 1, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,220.96 to AmerisourceBergen Drug Corp for GAMUNEX-C 10 gram/100 mL vials on November 10, 2025, with completion scheduled for December 3, 2025. This is a firm fixed-price, non-set-aside contract performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order valued at $9,308.80 to AmerisourceBergen Drug Corp for the supply of GAMUNEX-C 40 gram/400 mL vials. The award, issued on November 3, 2025, with an ultimate completion date of November 25, 2025, represents a firm fixed-price contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location. This delivery order is part of the company's...
- The Defense Logistics Agency awarded a $55,852.80 delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 40 gram/400 ml vials on October 23, 2025, with an ultimate completion date of November 14, 2025. This firm fixed-price contract is non-set-aside and represents a competitive award for pharmaceutical supply to support federal medical procurement needs. The award was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $7,325.64 to AmerisourceBergen Drug Corp for GAMUNEX-C, a 10 gram/100 mL immunoglobulin vial product, with an ultimate completion date of August 21, 2025. This competitive award, issued on July 31, 2025, utilizes a firm fixed price contract type with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order valued at $3,036.70 to AmerisourceBergen Drug Corp for the supply of GAMUNEX-C 5 gram/50 milliliter vials. This firm fixed-price contract, issued on July 31, 2025, with an ultimate completion date of August 21, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of GAMUNEX-C 20 gram/200 milliliter vials valued at $11,801.40 with a firm fixed price. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract involves no set-aside designation and was competitively...
- The Defense Logistics Agency awarded a delivery order valued at $6,040.44 to AmerisourceBergen Drug Corp for GAMUNEX-C, a 40-gram/400-milliliter immunoglobulin vial. The contract was competitively awarded without set-aside designation and is scheduled for completion by May 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform fulfillment from its corporate office location. This delivery order represents a firm fixed price transaction for specialized...
- The Defense Logistics Agency awarded a delivery order valued at $13,963.20 to AmerisourceBergen Drug Corp for GAMUNEX-C, a 40-gram/400-milliliter immune globulin vial, with an ultimate completion date of November 25, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and will be performed at the awardee's location in Conshohocken, Pennsylvania. The delivery order represents a routine medical supply transaction executed under AmerisourceBergen's larger...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9F66Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $16,001.00 for GAMUNEX-C 5 gram/50 mL vials on November 14, 2025, with a completion date of December 8, 2025. This firm fixed-price contract is a non-set-aside award issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. As a child contract under the comprehensive global pharmaceutical support IDC, this delivery order exemplifies the company's role in supplying specialized pharmaceutical products across multiple therapeutic domains to the Defense Health Agency and other government healthcare systems. The award reflects the competitive procurement approach used by DLA for its medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.0k | 11/14/25 |